A2A NEWS

Search
  • A2A Pharma

Updated: Feb 7, 2020

A2A participated at the AI Applications Summit Biopharma discussing the urgency to advance AI applications in industry to bring benefits to patients faster


LEARN MORE

  • A2A Pharma

Updated: Feb 7, 2020

A2A Founder & CEO Edward Painter was a panelist at BIO Investor forum panel entitled "Applying artificial intelligence to improve therapy development today"


LEARN MORE

  • A2A Pharma

Updated: Feb 7, 2020

Insilico and A2A launched new Deuchenne-focused AI drug company


LEARN MORE